Filep J and Rosenkranz B |
Mechanism of vasopressin-induced platelet aggregation. |
1987 |
Thromb. Res. |
pmid:3105115
|
Ushiyama S et al. |
RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action. |
1988 |
Thromb. Res. |
pmid:3175990
|
Kosaki G et al. |
The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. |
1980 Dec 1-15 |
Thromb. Res. |
pmid:6785893
|
Anfossi G et al. |
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. |
1995 |
Thromb. Res. |
pmid:7778055
|
Lee GY et al. |
Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester. |
2005 |
Thromb. Res. |
pmid:15668191
|
Ljungberg B et al. |
Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors. |
1988 |
Thromb. Res. |
pmid:2847353
|
Boyd JA and Eling TE |
Prostaglandin release and the interaction of platelets with the pulmonary vasculature of rat and guinea pig. |
1980 Jul 1-15 |
Thromb. Res. |
pmid:7003800
|
Pekonen F et al. |
Platelet function and coagulation in normal and preeclamptic pregnancy. |
1986 |
Thromb. Res. |
pmid:2944245
|
Saldeen P et al. |
Thromboxane production in umbilical vein grafts. |
1984 |
Thromb. Res. |
pmid:6546814
|
Chou TC and Li CY |
Inhibitory mechanisms of dantrolene on platelet aggregation. |
1999 |
Thromb. Res. |
pmid:10593433
|
Vanags D et al. |
The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery. |
1990 |
Thromb. Res. |
pmid:2264023
|
Cerskus AL et al. |
Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone. |
1980 |
Thromb. Res. |
pmid:7414555
|
Rostagno C et al. |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil. |
1991 |
Thromb. Res. |
pmid:1754998
|
Castaldi PA et al. |
Evidence for a platelet membrane defect in the myeloproliferative syndromes. |
1982 |
Thromb. Res. |
pmid:6960545
|
Kankuri E et al. |
Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro. |
2003 |
Thromb. Res. |
pmid:14592552
|
Catella F and FitzGerald GA |
Paired analysis of urinary thromboxane B2 metabolites in humans. |
1987 |
Thromb. Res. |
pmid:3686481
|
Vericel E et al. |
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. |
1988 |
Thromb. Res. |
pmid:3129819
|
Arruzazabala ML et al. |
Effects of Policosanol on platelet aggregation in rats. |
1993 |
Thromb. Res. |
pmid:8475481
|
Riess H et al. |
Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic disease. |
1984 |
Thromb. Res. |
pmid:6237460
|
Cattaneo M et al. |
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. |
1991 |
Thromb. Res. |
pmid:1926062
|
Patrono C et al. |
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368167
|
Koh H et al. |
A radioimmunoassay of thromboxane B2 with thromboxane B2-125I-tyramide and its application to the study on the thromboxane B2 formation during platelet aggregation. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368170
|
Kohda N et al. |
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. |
1999 |
Thromb. Res. |
pmid:10593428
|
Winther K et al. |
Platelet function and fibrinolytic activity in cervical spinal cord injured patients. |
1992 |
Thromb. Res. |
pmid:1321515
|
Chetty N and Bradlow BA |
The effects of a vegetarian diet on platelet function and fatty acids. |
1983 |
Thromb. Res. |
pmid:6612688
|
Lee TK et al. |
Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke. |
1987 |
Thromb. Res. |
pmid:3629557
|
Tanoue K et al. |
A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa. |
1987 |
Thromb. Res. |
pmid:3629560
|
Petroni A et al. |
Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. |
1995 |
Thromb. Res. |
pmid:7482432
|
De La Cruz JP et al. |
Antithrombotic potential of olive oil administration in rabbits with elevated cholesterol. |
2000 |
Thromb. Res. |
pmid:11113274
|
Barnhart MI et al. |
DDAVP: does the drug have a direct effect on the vessel wall? |
1983 |
Thromb. Res. |
pmid:6415852
|
Davì G et al. |
Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs. |
1985 |
Thromb. Res. |
pmid:2933846
|
Saldeen P and Saldeen T |
6-keto-prostaglandin F1 alpha/thromboxane B2 ratio in vascular and lung tissue. |
1983 |
Thromb. Res. |
pmid:6688484
|
Teng CM et al. |
Inhibition of thrombin- and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist--denudatin B, an isomer of kadsurenone. |
1990 |
Thromb. Res. |
pmid:2169076
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Lagarde M et al. |
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. |
1980 |
Thromb. Res. |
pmid:7466751
|
McGill D et al. |
Platelet function and exercise-induced myocardial ischaemia in coronary heart disease patients. |
1989 |
Thromb. Res. |
pmid:2533414
|
Li C et al. |
Aspirin response variability after major orthopedic surgery. |
2012 |
Thromb. Res. |
pmid:22575418
|
Takasaki W et al. |
Enzyme immunoassay of human plasma 11-dehydrothromboxane B2. |
1991 |
Thromb. Res. |
pmid:1957275
|
Toft G et al. |
Intravenously and topically applied magnesium in the prevention of arterial thrombosis. |
2000 |
Thromb. Res. |
pmid:10904104
|
Riess H et al. |
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients. |
1986 |
Thromb. Res. |
pmid:3012819
|
Pirich C et al. |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. |
1999 |
Thromb. Res. |
pmid:10588465
|
Altman R et al. |
Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma. |
1986 |
Thromb. Res. |
pmid:3014677
|
Yamaguchi A et al. |
Effect of cetiedil on platelet aggregation and thromboxane synthesis. |
1985 |
Thromb. Res. |
pmid:2986312
|
Lai LJ et al. |
Trilinolein inhibits epinephrine-induced human platelet aggregation. |
1994 |
Thromb. Res. |
pmid:7863478
|
Perneby C et al. |
Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. |
1999 |
Thromb. Res. |
pmid:10632465
|
Schorer AE and White JG |
Interleukin 1 enhances arterial thrombogenicity in vitro. |
1989 |
Thromb. Res. |
pmid:2609290
|
Udvardy M et al. |
Altered primary haemostasis in Conn's syndrome. |
1992 |
Thromb. Res. |
pmid:1448795
|
Lukaszyk A et al. |
Does acute experimental pancreatitis affect blood platelet function? |
1989 |
Thromb. Res. |
pmid:2524119
|
Swart SS et al. |
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. |
1984 |
Thromb. Res. |
pmid:6326344
|
Alessandrini P et al. |
Physiologic variables affecting thromboxane B2 production in human whole blood. |
1985 |
Thromb. Res. |
pmid:3983893
|